
Moderna, Merck Cancer Vaccine Shows Promise in Late-Stage Melanoma Trial
Moderna and Merck’s experimental personalised cancer vaccine has delivered positive results in its first Phase 3 trial, sending Moderna shares

Moderna and Merck’s experimental personalised cancer vaccine has delivered positive results in its first Phase 3 trial, sending Moderna shares












Get notified about new articles